Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 4

Results: 14

MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 462, doi. 10.1038/onc.2012.69

By:

Agarwal, N;
Adhikari, A S;
Iyer, S V;
Hekmatdoost, K;
Welch, D R;
Iwakuma, T

Publication type:

Article

The nuclear cofactor RAC3/AIB1/SRC-3 enhances Nrf2 signaling by interacting with transactivation domains.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 514, doi. 10.1038/onc.2012.59

By:

Kim, J-H;
Yu, S;
Chen, J D;
Kong, A N

Publication type:

Article

Endometrial carcinoma: molecular alterations involved in tumor development and progression.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 403, doi. 10.1038/onc.2012.76

By:

Yeramian, A;
Moreno-Bueno, G;
Dolcet, X;
Catasus, L;
Abal, M;
Colas, E;
Reventos, J;
Palacios, J;
Prat, J;
Matias-Guiu, X

Publication type:

Article

Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effect.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 479, doi. 10.1038/onc.2012.64

By:

Klokov, D;
Leskov, K;
Araki, S;
Zou, Y;
Goetz, E M;
Luo, X;
Willson, D;
Boothman, D A

Publication type:

Article

hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 536, doi. 10.1038/onc.2012.568

By:

Massard, C;
Zermati, Y;
Pauleau, A-L;
Larochette, N;
Métivier, D;
Sabatier, L;
Kroemer, G;
Soria, J-C

Publication type:

Article

UVB-induced COX-2 expression requires histone H3 phosphorylation at Ser10 and Ser28.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 444, doi. 10.1038/onc.2012.71

By:

Keum, Y-S;
Kim, H-G;
Bode, A M;
Surh, Y-J;
Dong, Z

Publication type:

Article

The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 471, doi. 10.1038/onc.2012.66

By:

Li, X;
Stevens, P D;
Yang, H;
Gulhati, P;
Wang, W;
Evers, B M;
Gao, T

Publication type:

Article

N-cadherin regulates mammary tumor cell migration through Akt3 suppression.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 422, doi. 10.1038/onc.2012.65

By:

Chung, S;
Yao, J;
Suyama, K;
Bajaj, S;
Qian, X;
Loudig, O D;
Eugenin, E A;
Phillips, G R;
Hazan, R B

Publication type:

Article

microRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 414, doi. 10.1038/onc.2012.68

By:

Muramatsu, F;
Kidoya, H;
Naito, H;
Sakimoto, S;
Takakura, N

Publication type:

Article

MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 431, doi. 10.1038/onc.2012.74

By:

Yu, Y-H;
Chen, H-A;
Chen, P-S;
Cheng, Y-J;
Hsu, W-H;
Chang, Y-W;
Chen, Y-H;
Jan, Y;
Hsiao, M;
Chang, T-Y;
Liu, Y-H;
Jeng, Y-M;
Wu, C-H;
Huang, M-T;
Su, Y-H;
Hung, M-C;
Chien, M-H;
Chen, C-Y;
Kuo, M-L;
Su, J-L

Publication type:

Article

S6K1 determines the metabolic requirements for BCR-ABL survival.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 453, doi. 10.1038/onc.2012.70

By:

Barger, J F;
Gallo, C A;
Tandon, P;
Liu, H;
Sullivan, A;
Grimes, H L;
Plas, D R

Publication type:

Article

Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 502, doi. 10.1038/onc.2012.60

By:

Shchors, K;
Nozawa, H;
Xu, J;
Rostker, F;
Swigart-Brown, L;
Evan, G;
Hanahan, D

Publication type:

Article

The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 491, doi. 10.1038/onc.2012.61

By:

Gao, P;
Xing, A-Y;
Zhou, G-Y;
Zhang, T-G;
Zhang, J-P;
Gao, C;
Li, H;
Shi, D-B

Publication type:

Article

Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.

Published in:

Oncogene, 2013, v. 32, n. 4, p. 528, doi. 10.1038/onc.2012.57

By:

Psallidas, I;
Stathopoulos, G T;
Maniatis, N A;
Magkouta, S;
Moschos, C;
Karabela, S P;
Kollintza, A;
Simoes, D C M;
Kardara, M;
Vassiliou, S;
Papiris, S A;
Roussos, C;
Kalomenidis, I

Publication type:

Article